Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice.
Desjardins EM, Wu J, Lavoie DCT, Ahmadi E, Townsend LK, Morrow MR, Wang D, Tsakiridis EE, Batchuluun B, Fayyazi R, Kwiecien JM, Tsakiridis T, Lally JSV, Paré G, Pinkosky SL, Steinberg GR. Desjardins EM, et al. Among authors: pare g. Cell Rep Med. 2023 Sep 19;4(9):101193. doi: 10.1016/j.xcrm.2023.101193. Cell Rep Med. 2023. PMID: 37729871 Free PMC article.
Proteome-Wide Changes in Blood Biomarkers During Hemodialysis.
Lanktree MB, Collister D, Pigyere M, Mazzetti A, Paré G, Walsh M. Lanktree MB, et al. Among authors: pare g. Kidney Int Rep. 2023 Nov 2;9(1):177-181. doi: 10.1016/j.ekir.2023.10.020. eCollection 2024 Jan. Kidney Int Rep. 2023. PMID: 38312796 Free PMC article. No abstract available.
What Causes Premature Coronary Artery Disease?
Le A, Peng H, Golinsky D, Di Scipio M, Lali R, Paré G. Le A, et al. Among authors: pare g. Curr Atheroscler Rep. 2024 Jun;26(6):189-203. doi: 10.1007/s11883-024-01200-y. Epub 2024 Apr 4. Curr Atheroscler Rep. 2024. PMID: 38573470 Review.
Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
Yanagihara T, Tsubouchi K, Zhou Q, Chong M, Otsubo K, Isshiki T, Schupp JC, Sato S, Scallan C, Upagupta C, Revill S, Ayoub A, Chong SG, Dvorkin-Gheva A, Kaminski N, Tikkanen J, Keshavjee S, Paré G, Guignabert C, Ask K, Kolb MRJ. Yanagihara T, et al. Among authors: pare g. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1498-1514. doi: 10.1164/rccm.202109-2174OC. Am J Respir Crit Care Med. 2023. PMID: 36917778
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial.
Mehta SR, Pare G, Lonn EM, Jolly SS, Natarajan MK, Pinilla-Echeverri N, Schwalm JD, Sheth TN, Sibbald M, Tsang M, Valettas N, Velianou JL, Lee SF, Ferdous T, Nauman S, Nguyen H, McCready T, McQueen MJ. Mehta SR, et al. Among authors: pare g. EuroIntervention. 2022 Dec 2;18(11):e888-e896. doi: 10.4244/EIJ-D-22-00735. EuroIntervention. 2022. PMID: 36349701 Free PMC article. Clinical Trial.
509 results